Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Infectious Disease

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1452670

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1452670

Single Domain Antibody Platforms Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

PUBLISHED:
PAGES: 291 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

Description

Table of Contents

The global single domain antibody platforms market, expected to achieve a remarkable compound annual growth rate (CAGR) of 13% from 2024 to 2031. The market valued at US$ 30 million and is projected to soar to US$ 70 million by the end of 2031. This growth trajectory underscores the escalating demand for innovative healthcare solutions and the increasing prevalence of immune disorders, viral infections, and cancer worldwide.

Dominance of Pharmaceutical and Biotechnology Applications

In 2022, single domain antibodies were predominantly used in pharmaceutical and biotechnology companies, capturing over 39% of the market share. They accounted for 6.1% of the global custom antibody market, showcasing their substantial contribution and promising growth prospects.

In-depth Analysis of Market Dynamics

The global market has witnessed a steady growth, driven by the growing incidence of diseases requiring advanced treatment options. Research and development (R&D) investments are anticipated to surge, bolstering market growth further. Significant federal funding for cancer research, including a notable increase for the National Cancer Institute, underscores the sector's potential for innovation and advancement.

Pioneering Breakthroughs and Collaborative Ventures

The market is ripe with opportunities, as single domain antibody platform manufacturers prioritize innovative drug development and strategic collaborations. Recent years have seen groundbreaking approvals, such as Sanofi's Cablivi, and partnerships aimed at expanding antibody-drug pipelines and distribution networks. These efforts are set to propel the market forward, offering promising prospects for healthcare advancements.

Navigating Challenges

Despite the optimistic outlook, the market faces hurdles such as stringent regulatory approvals, a scarcity of skilled professionals, and the high maintenance costs associated with antibodies. Addressing these challenges will be crucial for sustaining growth and innovation in the single domain antibody platforms market.

Regional Market Insights

The United States is poised to maintain its leading position in the North American market, driven by an increasing number of cancer cases and a strong focus on developing enhanced treatment options. Germany and China are also highlighted as key markets, with high levels of research activity and strategic collaborations contributing to their growth. India's favorable government policies for start-ups and MNCs present additional growth opportunities, particularly in the biotechnology sector.

Looking Ahead: A Future of Innovation and Growth

The single domain antibody platforms market stands at the threshold of a transformative era, with technological advancements and strategic partnerships shaping its trajectory. As the demand for advanced healthcare solutions continues to rise, the market is poised for substantial growth, offering new opportunities for treatment and research. With a steadfast focus on innovation, collaboration, and overcoming challenges, the future looks promising for single domain antibody platforms, marking a significant step forward in the global healthcare industry.

Competitive Analysis

Leading providers in the single domain antibody platform market are focusing on collaborations, accreditations, and innovative drug development to enhance their market presence. Notable developments include licensing agreements and GMP accreditation for new manufacturing facilities, signaling a competitive and dynamic market landscape.

Key Companies Profiled

  • Creative BioLabs A
  • Synbio Technologies
  • ProSci Incorporated
  • BioCat GmbH
  • Antibody Design Labs
  • GenScript
  • Oak BioSciences, Inc
  • Rockland Immunochemicals, Inc
  • Hybrigenics Services
  • NeoClone Biotechnology International LLC
  • Kaneka Eurogentec S.A
  • ProteoGenix

Market Segmentation:

The multispecific single domain antibody segment is expected to dominate, reflecting the growing demand for antibodies that can target multiple antigens. Camelid antibodies, known for their small size and versatility, are projected to lead among animal sources. Therapeutic development remains the most popular application, driven by the effectiveness of single domain antibodies in immune therapy, cancer treatment, and antiviral therapy.

Single Domain Antibody Platforms Market by Platform Type:

  • Multi-specific Single-domain Antibody
  • Bispecific Single-domain Antibody
  • Multivalent Single-domain Antibody
  • Mono-specific Single-domain Antibody

Single Domain Antibody Platforms Market by Animal Source:

  • Camelids
  • Camels
  • Llamas
  • Alpacas
  • Sharks

Single Domain Antibody Platforms Market by Application:

  • Diagnostic Development
  • Therapeutic Development
  • Research & Developmental Activities

Single Domain Antibody Platforms Market by End User:

  • Diagnostic Laboratories
  • Clinical Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies

Single Domain Antibody Platforms Market by Region:

  • North America Single Domain Antibody Platforms Market
  • Latin America Single Domain Antibody Platforms Market
  • Europe Single Domain Antibody Platforms Market
  • South Asia Single Domain Antibody Platforms Market
  • East Asia Single Domain Antibody Platforms Market
  • Oceania Single Domain Antibody Platforms Market
  • Middle East & Africa Single Domain Antibody Platforms Market
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Single Domain Antibody Platforms Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Single Domain Antibody Platforms Market Outlook, 2018 - 2031

  • 3.1. Global Single Domain Antibody Platforms Market Outlook, by Platform Type, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Implantable device
      • 3.1.1.2. External devices
  • 3.2. Global Single Domain Antibody Platforms Market Outlook, by Animal Source, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Spinal Cord Stimulation
      • 3.2.1.2. Deep Brain Stimulation
      • 3.2.1.3. Sacral Nerve Stimulation
      • 3.2.1.4. Vagus Nerve Stimulation
      • 3.2.1.5. Cochlear Implants
      • 3.2.1.6. Gastric Electric Stimulation
  • 3.3. Global Single Domain Antibody Platforms Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Transcutaneous Electrical Nerve Stimulation
      • 3.3.1.2. Transcranial Magnetic Stimulation
  • 3.4. Global Single Domain Antibody Platforms Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Pain Management
      • 3.4.1.2. Parkinson's Disease
      • 3.4.1.3. Urinary and Fecal Incontinence
      • 3.4.1.4. Epilepsy
      • 3.4.1.5. Hearing loss
      • 3.4.1.6. Gastroparesis
      • 3.4.1.7. Depression
  • 3.5. Global Single Domain Antibody Platforms Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Single Domain Antibody Platforms Market Outlook, 2018 - 2031

  • 4.1. North America Single Domain Antibody Platforms Market Outlook, by Platform Type, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Implantable device
      • 4.1.1.2. External devices
  • 4.2. North America Single Domain Antibody Platforms Market Outlook, by Animal Source, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Spinal Cord Stimulation
      • 4.2.1.2. Deep Brain Stimulation
      • 4.2.1.3. Sacral Nerve Strimulation
      • 4.2.1.4. Vagus Nerve Stimulation
      • 4.2.1.5. Cochlear Implants
      • 4.2.1.6. Gastric Electric Stimulation
  • 4.3. North America Single Domain Antibody Platforms Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Transcutaneous Electrical Nerve Stimulation
      • 4.3.1.2. Transcranial Magnetic Stimulation
  • 4.4. North America Single Domain Antibody Platforms Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Pain Management
      • 4.4.1.2. Parkinson's Disease
      • 4.4.1.3. Urinary and Fecal Incontinence
      • 4.4.1.4. Epilepsy
      • 4.4.1.5. Hearing loss
      • 4.4.1.6. Gastroparesis
      • 4.4.1.7. Depression
  • 4.5. North America Single Domain Antibody Platforms Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.2. U.S. Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 4.5.1.3. U.S. Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.5.1.4. U.S. Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.5.1.5. Canada Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.6. Canada Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 4.5.1.7. Canada Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.5.1.8. Canada Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Single Domain Antibody Platforms Market Outlook, 2018 - 2031

  • 5.1. Europe Single Domain Antibody Platforms Market Outlook, by Platform Type, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Implantable device
      • 5.1.1.2. External devices
  • 5.2. Europe Single Domain Antibody Platforms Market Outlook, by Animal Source, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Spinal Cord Stimulation
      • 5.2.1.2. Deep Brain Stimulation
      • 5.2.1.3. Sacral Nerve Stimulation
      • 5.2.1.4. Vagus Nerve Stimulation
      • 5.2.1.5. Cochlear Implants
      • 5.2.1.6. Gastric Electric Stimulation
  • 5.3. Europe Single Domain Antibody Platforms Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Transcutaneous Electrical Nerve Stimulation
      • 5.3.1.2. Transcranial Magnetic Stimulation
  • 5.4. Europe Single Domain Antibody Platforms Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Pain Management
      • 5.4.1.2. Parkinson's Disease
      • 5.4.1.3. Urinary and Fecal Incontinence
      • 5.4.1.4. Epilepsy
      • 5.4.1.5. Hearing loss
      • 5.4.1.6. Gastroparesis
      • 5.4.1.7. Depression
  • 5.5. Europe Single Domain Antibody Platforms Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.2. Germany Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 5.5.1.3. Germany Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.4. Germany Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.5. U.K. Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.6. U.K. Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 5.5.1.7. U.K. Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.8. U.K. Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.9. France Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.10. France Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 5.5.1.11. France Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.12. France Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.13. Italy Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.14. Italy Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 5.5.1.15. Italy Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.16. Italy Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.17. Turkey Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.18. Turkey Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 5.5.1.19. Turkey Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.20. Turkey Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.21. Russia Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.22. Russia Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 5.5.1.23. Russia Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.24. Russia Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Single Domain Antibody Platforms Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Single Domain Antibody Platforms Market Outlook, by Platform Type, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Implantable device
      • 6.1.1.2. External devices
  • 6.2. Asia Pacific Single Domain Antibody Platforms Market Outlook, by Animal Source, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Spinal Cord Stimulation
      • 6.2.1.2. Deep Brain Stimulation
      • 6.2.1.3. Sacral Nerve Stimulation
      • 6.2.1.4. Vagus Nerve Stimulation
      • 6.2.1.5. Cochlear Implants
      • 6.2.1.6. Gastric Electric Stimulation
  • 6.3. Asia Pacific Single Domain Antibody Platforms Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Transcutaneous Electrical Nerve Stimulation
      • 6.3.1.2. Transcranial Magnetic Stimulation
  • 6.4. Asia Pacific Single Domain Antibody Platforms Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Pain Management
      • 6.4.1.2. Parkinson's Disease
      • 6.4.1.3. Urinary and Fecal Incontinence
      • 6.4.1.4. Epilepsy
      • 6.4.1.5. Hearing loss
      • 6.4.1.6. Gastroparesis
      • 6.4.1.7. Depression
  • 6.5. Asia Pacific Single Domain Antibody Platforms Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.2. China Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 6.5.1.3. China Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.4. China Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.5. Japan Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.6. Japan Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 6.5.1.7. Japan Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.8. Japan Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.9. South Korea Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.10. South Korea Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 6.5.1.11. South Korea Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.12. South Korea Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.13. India Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.14. India Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 6.5.1.15. India Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.16. India Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Single Domain Antibody Platforms Market Outlook, 2018 - 2031

  • 7.1. Latin America Single Domain Antibody Platforms Market Outlook, by Platform Type, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Implantable device
      • 7.1.1.2. External devices
  • 7.2. Latin America Single Domain Antibody Platforms Market Outlook, by Animal Source, Value (US$ Mn), 2018 - 2031
    • 7.2.1.1. Spinal Cord Stimulation
    • 7.2.1.2. Deep Brain Stimulation
    • 7.2.1.3. Sacral Nerve Stimulation
    • 7.2.1.4. Vagus Nerve Stimulation
    • 7.2.1.5. Cochlear Implants
    • 7.2.1.6. Gastric Electric Stimulation
  • 7.3. Latin America Single Domain Antibody Platforms Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Transcutaneous Electrical Nerve Stimulation
      • 7.3.1.2. Transcranial Magnetic Stimulation
  • 7.4. Latin America Single Domain Antibody Platforms Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Pain Management
      • 7.4.1.2. Parkinson's Disease
      • 7.4.1.3. Urinary and Fecal Incontinence
      • 7.4.1.4. Epilepsy
      • 7.4.1.5. Hearing loss
      • 7.4.1.6. Gastroparesis
      • 7.4.1.7. Depression
  • 7.5. Latin America Single Domain Antibody Platforms Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.2. Brazil Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 7.5.1.3. Brazil Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.5.1.4. Brazil Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.5.1.5. Mexico Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.6. Mexico Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 7.5.1.7. Mexico Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.5.1.8. Mexico Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.5.1.9. Argentina Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.10. Argentina Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 7.5.1.11. Argentina Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.5.1.12. Argentina Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Single Domain Antibody Platforms Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Single Domain Antibody Platforms Market Outlook, by Platform Type, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Implantable device
      • 8.1.1.2. External devices
  • 8.2. Middle East & Africa Single Domain Antibody Platforms Market Outlook, by Animal Source, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Spinal Cord Stimulation
      • 8.2.1.2. Deep Brain Stimulation
      • 8.2.1.3. Sacral Nerve Stimulation
      • 8.2.1.4. Vagus Nerve Stimulation
      • 8.2.1.5. Cochlear Implants
      • 8.2.1.6. Gastric Electric Stimulation
  • 8.3. Middle East & Africa Single Domain Antibody Platforms Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Transcutaneous Electrical Nerve Stimulation
      • 8.3.1.2. Transcranial Magnetic Stimulation
  • 8.4. Middle East & Africa Single Domain Antibody Platforms Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Pain Management
      • 8.4.1.2. Parkinson's Disease
      • 8.4.1.3. Urinary and Fecal Incontinence
      • 8.4.1.4. Epilepsy
      • 8.4.1.5. Hearing loss
      • 8.4.1.6. Gastroparesis
      • 8.4.1.7. Depression
  • 8.5. Middle East & Africa Single Domain Antibody Platforms Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.2. GCC Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 8.5.1.3. GCC Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.5.1.4. GCC Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.5. South Africa Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.6. South Africa Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 8.5.1.7. South Africa Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.5.1.8. South Africa Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.9. Egypt Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.10. Egypt Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 8.5.1.11. Egypt Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.5.1.12. Egypt Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.13. Nigeria Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.14. Nigeria Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 8.5.1.15. Nigeria Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.5.1.16. Nigeria Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Single Domain Antibody Platforms Market by Platform Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Single Domain Antibody Platforms Market by Animal Source, Value (US$ Mn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Single Domain Antibody Platforms Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Single Domain Antibody Platforms Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Application vs By Animal Source Heatmap
  • 9.2. Manufacturer vs By Animal Source Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Creative BioLabs A
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Synbio Technologies
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. ProSci Incorporated
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. BioCat GmbH
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Antibody Design Labs
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. GenScript
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Oak BioSciences, Inc
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Rockland Immunochemicals, Inc
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Hybrigenics Services
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. NeoClone Biotechnology International LLC
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Kaneka Eurogentec S.A
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. ProteoGenix
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development

10. Appendix

  • 10.1.Research Methodology
  • 10.2.Report Assumptions
  • 10.3.Acronyms and Abbreviations

List of Region/Countries

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Turkey
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!